Disease & disorder
limited cutaneous systemic sclerosis
MONDO:0016358
Limited cutaneous systemic sclerosis (lcSSc) is a subtype of systemic sclerosis (SSc) characterized by the association of Raynaud's phenomenon with skin fibrosis limited to the hands, face, feet and forearms.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
1 shownDrugs being studied
Research locations
BaltimoreMaryland, United States1BostonMassachusetts, United States1CharlestonSouth Carolina, United States1DallasTexas, United States1Los AngelesCalifornia, United States1New YorkNew York, United States1OmahaNebraska, United States1PhiladelphiaPennsylvania, United States1TucsonArizona, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.